GUSTO-IV ACS Investigators[Corporate Author] - Search Results

Year	Number of Results
2001	1
2003	2
2004	3
2007	2
2024	0

1

Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in women.

Westerhout CM, Lauer MS, James S, Fu Y, Wallentin L, Armstrong PW; GUSTO IV ACS Investigators. Westerhout CM, et al. Eur Heart J. 2007 Sep;28(17):2064-9. doi: 10.1093/eurheartj/ehm223. Epub 2007 Jun 28. Eur Heart J. 2007. PMID: 17600040 Clinical Trial.

2

Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS.

Lenderink T, Boersma E, Ruzyllo W, Widimsky P, Ohman EM, Armstrong PW, Wallentin L, Simoons ML; GUSTO IV-ACS Investigators. Lenderink T, et al. Am Heart J. 2004 May;147(5):865-73. doi: 10.1016/j.ahj.2003.11.009. Am Heart J. 2004. PMID: 15131544 Clinical Trial.

3

Long-term results after the glycoprotein IIb/IIIa inhibitor abciximab in unstable angina: one-year survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV--Acute Coronary Syndrome) Trial.

Ottervanger JP, Armstrong P, Barnathan ES, Boersma E, Cooper JS, Ohman EM, James S, Topol E, Wallentin L, Simoons ML; GUSTO IV-ACS Investigators. Ottervanger JP, et al. Circulation. 2003 Jan 28;107(3):437-42. doi: 10.1161/01.cir.0000046487.06811.5e. Circulation. 2003. PMID: 12551868 Clinical Trial.

4

Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS.

Ottervanger JP, Armstrong P, Barnathan ES, Boersma E, Cooper JS, Ohman EM, James S, Wallentin L, Simoons ML; GUSTO IV-ACS Investigators. Ottervanger JP, et al. Eur Heart J. 2004 Sep;25(17):1494-501. doi: 10.1016/j.ehj.2004.07.004. Eur Heart J. 2004. PMID: 15342168 Clinical Trial.

5

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial.

Simoons ML; GUSTO IV-ACS Investigators. Simoons ML, et al. Lancet. 2001 Jun 16;357(9272):1915-24. doi: 10.1016/s0140-6736(00)05060-1. Lancet. 2001. PMID: 11425411 Clinical Trial.

6

Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy.

James SK, Armstrong P, Barnathan E, Califf R, Lindahl B, Siegbahn A, Simoons ML, Topol EJ, Venge P, Wallentin L; GUSTO-IV-ACS Investigators. James SK, et al. J Am Coll Cardiol. 2003 Mar 19;41(6):916-24. doi: 10.1016/s0735-1097(02)02969-8. J Am Coll Cardiol. 2003. PMID: 12651034 Free article.

7

A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes.

James SK, Lindahl B, Armstrong P, Califf R, Simoons ML, Venge P, Wallentin L; GUSTO-IV ACS Investigators. James SK, et al. Int J Cardiol. 2004 Feb;93(2-3):113-20. doi: 10.1016/S0167-5273(03)00157-8. Int J Cardiol. 2004. PMID: 14975536 Clinical Trial.

8

No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trial.

Westerhout CM, Gnarpe J, Chang WC, FitzPatrick S, Barnathan ES, Boersma E, Califf RM, Wallentin L, Simoons ML, Armstrong PW; GUSTO IV ACS Investigators. Westerhout CM, et al. Am Heart J. 2007 Aug;154(2):306-12. doi: 10.1016/j.ahj.2007.04.010. Am Heart J. 2007. PMID: 17643581

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year